22.55USD-5.29%Mkt Cap: 233.52M $P/E: —1d ago
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of …
Industry Peers
Diagnostics & Researchvs Diagnostics & Research
P/B
Pricier
1M Perf
Lower
$186.32BUSDP/E 27.6
$134.82BUSDP/E 36.8
$43.51BUSDP/E 42.0
$41.53BUSDP/E 38.7
$38.88BUSD
$37.53BUSDP/E 26.7
$36.82BUSDP/E 47.7
$32.25BUSDP/E 24.0
$26.60BUSDP/E 31.9
$25.82BUSDP/E 30.0
$23.46BUSDP/E 23.4
$22.96BUSDP/E 24.8
$19.89BUSD
$15.12BUSDP/E 33.3
$12.91BUSDP/E 26.9
$12.41BUSDP/E 53.5
$10.92BUSD
$8.81BUSDP/E 20.6
$6.41BUSD
$5.52BUSDP/E 222.2
$5.06BUSDP/E 43.3
$4.85BUSD
$4.69BUSDP/E 54.4
$3.65BUSDP/E 25.7
$3.43BUSD
$2.93BUSD
$2.04BUSD
$1.90BUSD
$1.48BUSDP/E 37.4
$1.48BUSDP/E 22.4
$1.47BUSD
$1.40BUSD
$1.13BUSD
$1.01BUSDP/E 21.1
$723.37MUSD
$615.20MUSDP/E 40.1
$582.78MUSD
$539.30MUSD
$297.38MUSDP/E 3.0
$282.06MUSD
$190.51MUSD
$147.80MUSD
$112.34MUSD
$94.30MUSDP/E 18.2
$77.88MUSD
$58.94MUSD
$44.26MUSD
$27.97MUSD
$27.15MUSD
$22.69MUSD
$17.60MUSD
$12.55MUSD
$10.07MUSDP/E 63.2
$9.85MUSD
$9.02MUSD
$8.78MUSD
$6.77MUSD
$6.29MUSD
$5.98MUSD
$5.10MUSD
$4.66MUSD
$3.81MUSD
$3.86MUSDP/E 2.8
$2.93MUSD
$2.79MUSD
$2.43MUSD
$1.29MUSD
$314.2KUSDP/E Infinity
$14.0KUSD
Indicators:|
Key Statistics
Company
Market Cap233.52M $
Enterprise Value275.94M $
Revenue (TTM)96.10M $
Gross Profit71.78M $
Net Income (TTM)-35.27M $
Revenue/Share11.80 USD
Last Price22.55 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees334
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-102.50
PEG—
EV/EBITDA-14.03
EV/Revenue2.87
P/S2.43
P/B24.94
EPS (TTM)-3.96
EPS (Forward)-0.22
52W Range
5.20091% of range24.23
52W High24.23 USD
52W Low5.200 USD
Profitability
Gross Margin81.11%
Oper. Margin-25.81%
EBITDA Margin-20.47%
Profit Margin-39.85%
ROE1430.63%
ROA-40.31%
Growth
Revenue Growth42.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.27M $
CapEx (TTM)403.00K $
FCF Margin-14.34%
FCF Yield-5.90%
Net Debt48.00M $
Net Debt/EBITDA-2.44
Balance Sheet
Debt/Equity-29.56
Current Ratio2.82
Quick Ratio2.42
Book Value/Sh0.9040 USD
Cash/Share2.530 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateSep 15, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)30.83 USD
Upside (mean)+36.7%
Target Range26.00 USD – 40.00 USD
$26.00+36.7% to mean$40.00
# Analysts6
Ownership
Shares Out.10.36M
Float4.47M
Insiders41.93%
Institutions39.81%
Short Interest
Short Ratio2.4d
Short % Float1.77%
Short % Out.1.01%
Shares Short104.67K
Short (prev mo.)137.20K
Technical
SMA 5014.89 (+51.4%)
SMA 20011.14 (+102.4%)
Beta0.59
S&P 52W Chg20.05%
Avg Vol (30d)67.06K
Avg Vol (10d)118.77K
Technical Indicators
RSI (14)72.2
MACD1.9774
MACD Signal1.2152
MACD Hist.+0.7622
BB Upper23.24 USD
BB Middle17.31 USD
BB Lower11.38 USD
BB Width68.50%
ATR (14)1.676 USD
Vol Ratio (20d)1.46x